New York, NY, United States of America

Shruti Bansal

This inventor holds 1 USPTO granted patent. Top assignee: Columbia University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shruti Bansal. Retrieved from https://idiyas.com/inventor/shruti-bansal-k4lcwqmh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shruti Bansal: Cancer Treatment Innovation

Introduction

Shruti Bansal is an inventor associated with Columbia University in New York, NY. Her patent work addresses a combination approach to cancer treatment.

Latest Patents

Bansal is associated with 1 patent, titled “Cancer treatment method combining immunotherapy and radiotherapy.” The disclosed method involves administering one or more adenosine signaling modulators alongside radiation therapy to a person being treated for cancer. In some embodiments, it also includes an immune-based therapy.

Career Highlights

Bansal’s listed invention focuses on combining treatment modalities, bringing together adenosine signaling modulation and radiotherapy, with immunotherapy included in certain embodiments. Her association with Columbia University connects this work to the university’s research environment.

Collaborations

Bansal’s listed coworker is Catherine S. Spina, who is a woman. The provided information identifies their association but does not specify further details about their collaboration.

Conclusion

Shruti Bansal’s patent work explores a combined approach to cancer treatment involving adenosine signaling modulators and radiation therapy, with immunotherapy as an option in some embodiments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…